Latest Industry Insights

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.

Explore how multiomics research combines genomics, proteomics, and transcriptomics to offer new insights in disease modeling and therapeutic advancements.

The diagnostics landscape has transformed over the last 12 months. In this interview, Mara Aspinall, a leader in diagnostic innovation, policy and partner at Illumina Ventures, reflected on the defining moments of the last year and what lies ahead.

Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being. Explore the latest weight loss research and learn how even moderate weight loss can transform metabolic health.

Following the Galien Forum, Technology Networks spoke with Sanket Shah, president of Otsuka Precision Health, to learn how the company is advocating for healthcare change by combining digital innovation with meaningful human connection.

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.

In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.

At the recent American Society for Mass Spectrometry conference in Baltimore, Technology Networks sat down with Dr. Nikhil Rao to learn more about Microscoop® Mint, an advanced sample preparation platform.

Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.